Oxford Immunotec Company

Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection (LTBI) and TB disease. T-SPOT ®. TB is an interferon gamma release assay (IGRA) which are designed to replace the century old Mantoux skin test (TST).
Technology: Cell Therapies
Industry: Personalized Medicine
Headquarters: Abingdon, Oxfordshire, United Kingdom
Founded Date: 2002
Employees Number: 501-1000
Funding Status: IPO

Visit Website
marketing@oxfordimmunotec.com
@TBDiagnosis
Register and Claim Ownership